Previous 10 |
A kind word means a lot Before I share my thoughts, I want to thank a kind reader who contacted me and said some encouraging things about my writing. I come to writing late in life, and never gave a thought to “Writer's Block,” it seemed like a precious, made-up thing for p...
NEW YORK, June 18, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ: RPRX) today announced the closing of the initial public offering of 89,333,920 shares of its Class A ordinary shares pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commissio...
Nova LifeStyle (NASDAQ: NVFY ) +105% . More news on: Nova LifeStyle, Inc., TDH Holdings, Inc., Rexahn Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Royalty Pharma (RPRX) jumped 58.9% on Tuesday, the latest and largest in a string of successful IPOs, particularly from the healthcare sector. Royalty Pharma raised $2.2 billion at a market cap of $16.7 billion, the largest US IPO in over a year. Backed by various private equity firms, hedge...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . A big turnaround on Wall Street was seen Monday as the S&P 500 erased a 2.5% drop on word that the Fed would begin buying in...
Royalty Pharma ( RPRX ) has priced IPO of 77,681,670 shares (upsized from 70,000,000) of its Class A ordinary shares at a price of $28.00/share. More news on: Royalty Pharma plc, Healthcare stocks news, , Read more ...
Following back-to-back eight-IPO weeks, the IPO market is taking a breather with just one IPO scheduled for the week ahead. That said, several companies could launch on Monday to price later in the week. Pharmaceutical royalty acquirer Royalty Pharma (RPRX) plans to raise $1.9 billion at a $...
Quick Take Royalty Pharma ( RPRX ) has filed to raise $1.86 billion in an IPO of its Class A shares, per an amended registration statement . The company purchases royalty interests in biopharmaceutical products and invests in clinical trial financings. RPRX is essentially a private equi...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Molly Sawaya as Executive Vice President, Head of Human Capital. Molly joins Royalty Pharma from Hudson Bay Capital, where she was a Managing Director and Head of Colleague Experie...
2024-07-24 08:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...